Gonorrhea Sexually Transmitted Disease Surveillance 2004
16
Gonorrhea Sexually Transmitted Disease Surveillance 2004 Division of STD Prevention
description
Gonorrhea Sexually Transmitted Disease Surveillance 2004. Division of STD Prevention. Gonorrhea — Rates: United States, 1970–2004 and the Healthy People 2010 target. Note: The Healthy People 2010 target for gonorrhea is 19.0 cases per 100,000 population. - PowerPoint PPT Presentation
Transcript of Gonorrhea Sexually Transmitted Disease Surveillance 2004
GonorrheaSexually Transmitted Disease
Surveillance 2004
Division of STD Prevention
Gonorrhea — Rates: United States, 1970–2004 and the Healthy People 2010 target
Note: The Healthy People 2010 target for gonorrhea is 19.0 cases per 100,000 population.
Rate (per 100,000 population)
Gonorrhea2010 Target
0
100
200
300
400
500
1970 73 76 79 82 85 88 91 94 97 2000 03
Gonorrhea — Reported cases by reporting source: United States, 1984–2004
Note: Prior to 1996, the STD clinic source of report corresponded to public (clinic) source of report, and the non-STD clinic category corresponded to private source of report. After 1996, as states began reporting morbidity data electronically, the specific source of report (i.e., STD clinic) began to be reported from an increasing number of states.
Cases (in thousands)
non-STD ClinicSTD Clinic
0
150
300
450
600
750
1984 86 88 90 92 94 96 98 2001 02 04
Gonorrhea — Rates by state: United States and outlying areas, 2004
Note: The total rate of gonorrhea for the United States and outlying areas (Guam, Puerto Rico and Virgin Islands) was 112.1 per 100,000 population. The Healthy People 2010 target is 19.0 cases per 100,000 population.
Rate per 100,000population
<=19.019.1-100.0>100.0
VT 13.9 NH 10.3 MA 47.5 RI 75.8 CT 82.2 NJ 77.5 DE 109.4 MD 150.6
Guam 69.7
Puerto Rico 6.9 Virgin Is. 68.9
(n= 8)(n= 25)(n= 20)
182.3
87.4
72.8151.8
85.0 67.1
109.2
181.7
94.9
7.5
162.8 110.6
42.4
93.367.0
234.4
16.1
172.4
58.4
248.6
161.6
9.6
65.9137.3
69.7
97.6
180.7
17.4
179.0
126.8
36.6
90.9
221.1
39.8
145.1
110.2
25.6
116.0
45.8
49.3
92.3
11.8
Gonorrhea — Rates by county: United States, 2004
Note: The Healthy People 2010 target for gonorrhea is 19.0 cases per 100,000 population.
Rate per 100,000population
<=19.0 (n= 1,330)
19.1-100.0 (n= 1,139)
>100.0 (n= 670)
Gonorrhea — Rates by region: United States, 1981–2004 and the HealthyPeople 2010 target
Note: The Healthy People 2010 target for gonorrhea is 19.0 cases per 100,000 population.
Rate (per 100,000 population)
WestMidwestNortheastSouth2010 Target
0
120
240
360
480
600
1981 83 85 87 89 91 93 95 97 99 2001 03
Gonorrhea — Rates by sex: United States, 1981–2004 and the Healthy People 2010 target
Note: The Healthy People 2010 target for gonorrhea is 19.0 cases per 100,000 population.
Rate (per 100,000 population)
MaleFemale2010 Target
0
120
240
360
480
600
1981 83 85 87 89 91 93 95 97 99 2001 03
Gonorrhea — Rates by race and ethnicity: United States, 1981–2004 and the Healthy People 2010 target
Note: The Healthy People 2010 target for gonorrhea is 19.0 cases per 100,000 population.
Rate (per 100,000 population)
WhiteBlackHispanicAsian/Pac IslAm Ind/AK Nat2010 Target
0
500
1,000
1,500
2,000
2,500
1981 83 85 87 89 91 93 95 97 99 2001 03
Gonorrhea — Age- and sex-specific rates: United States, 2004
Men Rate (per 100,000 population) Women
Age750 600 450 300 150 0 0 150 300 450 600 750
Total 65+55-6445-5440-4435-3930-3425-2920-2415-1910-145.8
Men Rate (per 100,000 population) Women
Age750 600 450 300 150 0 0 150 300 450 600 750
Total 65+55-6445-5440-4435-3930-3425-2920-2415-1910-14
252.9
Men Rate (per 100,000 population) Women
Age750 600 450 300 150 0 0 150 300 450 600 750
Total 65+55-6445-5440-4435-3930-3425-2920-2415-1910-14
430.6
Men Rate (per 100,000 population) Women
Age750 600 450 300 150 0 0 150 300 450 600 750
Total 65+55-6445-5440-4435-3930-3425-2920-2415-1910-14
302.1
Men Rate (per 100,000 population) Women
Age750 600 450 300 150 0 0 150 300 450 600 750
Total 65+55-6445-5440-4435-3930-3425-2920-2415-1910-14
178.6
Men Rate (per 100,000 population) Women
Age750 600 450 300 150 0 0 150 300 450 600 750
Total 65+55-6445-5440-4435-3930-3425-2920-2415-1910-14
124.5
Men Rate (per 100,000 population) Women
Age750 600 450 300 150 0 0 150 300 450 600 750
Total 65+55-6445-5440-4435-3930-3425-2920-2415-1910-14
89.6
Men Rate (per 100,000 population) Women
Age750 600 450 300 150 0 0 150 300 450 600 750
Total 65+55-6445-5440-4435-3930-3425-2920-2415-1910-14
48.1
Men Rate (per 100,000 population) Women
Age750 600 450 300 150 0 0 150 300 450 600 750
Total 65+55-6445-5440-4435-3930-3425-2920-2415-1910-14
17.0
Men Rate (per 100,000 population) Women
Age750 600 450 300 150 0 0 150 300 450 600 750
Total 65+55-6445-5440-4435-3930-3425-2920-2415-1910-14
4.1
Men Rate (per 100,000 population) Women
Age750 600 450 300 150 0 0 150 300 450 600 750
Total 65+55-6445-5440-4435-3930-3425-2920-2415-1910-14
110.2
Men Rate (per 100,000 population) Women
Age750 600 450 300 150 0 0 150 300 450 600 750
Total 65+55-6445-5440-4435-3930-3425-2920-2415-1910-14 36.9
Men Rate (per 100,000 population) Women
Age750 600 450 300 150 0 0 150 300 450 600 750
Total 65+55-6445-5440-4435-3930-3425-2920-2415-1910-14
610.9
Men Rate (per 100,000 population) Women
Age750 600 450 300 150 0 0 150 300 450 600 750
Total 65+55-6445-5440-4435-3930-3425-2920-2415-1910-14
569.1
Men Rate (per 100,000 population) Women
Age750 600 450 300 150 0 0 150 300 450 600 750
Total 65+55-6445-5440-4435-3930-3425-2920-2415-1910-14
269.7
Men Rate (per 100,000 population) Women
Age750 600 450 300 150 0 0 150 300 450 600 750
Total 65+55-6445-5440-4435-3930-3425-2920-2415-1910-14
114.2
Men Rate (per 100,000 population) Women
Age750 600 450 300 150 0 0 150 300 450 600 750
Total 65+55-6445-5440-4435-3930-3425-2920-2415-1910-14
60.3
Men Rate (per 100,000 population) Women
Age750 600 450 300 150 0 0 150 300 450 600 750
Total 65+55-6445-5440-4435-3930-3425-2920-2415-1910-14
32.9
Men Rate (per 100,000 population) Women
Age750 600 450 300 150 0 0 150 300 450 600 750
Total 65+55-6445-5440-4435-3930-3425-2920-2415-1910-14
11.7
Men Rate (per 100,000 population) Women
Age750 600 450 300 150 0 0 150 300 450 600 750
Total 65+55-6445-5440-4435-3930-3425-2920-2415-1910-14
2.5
Men Rate (per 100,000 population) Women
Age750 600 450 300 150 0 0 150 300 450 600 750
Total 65+55-6445-5440-4435-3930-3425-2920-2415-1910-14
0.6
Men Rate (per 100,000 population) Women
Age750 600 450 300 150 0 0 150 300 450 600 750
Total 65+55-6445-5440-4435-3930-3425-2920-2415-1910-14
116.7
Gonorrhea — Age-specific rates among women 10 to 44 years of age:United States, 1981–2004
Rate (per 100,000 population)
10-1415-1920-2425-2930-3435-3940-44
0
300
600
900
1,200
1,500
1981 83 85 87 89 91 93 95 97 99 2001 03
Gonorrhea — Age-specific rates among men 10 to 44 years of age:United States, 1981–2004
Rate (per 100,000 population)
10-1415-1920-2425-2930-3435-3940-44
0
400
800
1,200
1,600
2,000
1981 83 85 87 89 91 93 95 97 99 2001 03
Gonorrhea — Positivity among 15- to 24-year-old women tested in family planning
clinics by state: United States and outlying areas, 2004
*States/areas reported gonorrhea positivity data on less than 500 women aged 15-24 years during 2004. Note: Includes states that reported gonorrhea positivity data on at least 500 women aged 15-24 years screened during 2004 except for Maine, which submitted gonorrhea positivity data for April-December 2004, and Minnesota which submitted gonorrhea positivity data for January-March and July-December 2004.
SOURCE: Regional Infertility Prevention Projects; Office of Population Affairs; Local and State STD Control Programs; Centers forDisease Control and Prevention
Positivity (%)
See*<1.01.0-1.9>=2.0
VT 0.3 NH 0.2 MA RI CT 0.6 NJ 1.5 DE MD DC 0.9
Puerto Rico 0.2 Virgin Is. 3.2
(n= 12)(n= 24)(n= 11)(n= 6)
1.1
0.1
1.4
1.0 0.3
0.5
2.1
0.9
1.4 0.9
0.4
0.7 0.6
2.0
0.1
1.8
0.9
3.0
1.0
0.7
0.4 0.9
1.0
0.5
1.7
0.72.0
0.8
1.3
0.8
1.1
0.3
4.2
0.2
Gonococcal Isolate Surveillance Project (GISP) — Location of participating clinics and regional laboratories: United States, 2004
STD ClinicsClinics and Regional Labs
Birmingham Phoenix
Long Beach Los Angeles
Orange Co. San Diego
San Francisco Denver
Miami
Atlanta
Honolulu
Tripler AMC
Chicago
New Orleans
Baltimore
Detroit Minneapolis
St. Louis Las Vegas
Albuquerque
Greensboro
Cincinnati
Cleveland
Oklahoma City
Portland
Philadelphia
Dallas
Seattle
Gonococcal Isolate Surveillance Project (GISP) — Penicillin and tetracycline resistance among GISP isolates, 2004
Note: PPNG=penicillinase-producing N. gonorrhoeae; TRNG=plasmid-mediated tetracycline-resistant N. gonorrhoeae; PPNG-TRNG=plasmid-mediated penicillin- and tetracycline-resistant N. gonorrhoeae; PenR=chromosomally mediated penicillin resistant N. gonorrhoeae; TetR=chromosomally mediated tetracycline-resistant N. gonorrhoeae; CMRNG=chromosomally mediated penicillin- and tetracycline-resistant N. gonorrhoeae.
Susceptible
PPNG
TRNG
PPNG/TRNG
PenR
TetR
CMRNG
84.1%
0.6%
3.4%0.5%1.1%
6.1%
4.3%
Gonococcal Isolate Surveillance Project (GISP) — Percent of Neisseria gonorrhoeae isolates with resistance or intermediate resistance to ciprofloxacin,
1990–2004
Note: Resistant isolates have ciprofloxacin MICs ≥ 1 µg/ml. Isolates with intermediate resistance have ciprofloxacin MICs of 0.125 - 0.5 µg/ml. Susceptibility to ciprofloxacin was first measured in GISP in 1990.
Percent
Resistance
Intermediate resistance
0.0
2.0
4.0
6.0
8.0
10.0
1990 91 92 93 94 95 96 97 98 99 2000 01 02 03 04
Gonococcal Isolate Surveillance Project (GISP) — Percent of Neisseria gonorrhoeae isolates with resistance to ciprofloxacin by sexual behavior,
2001–2004
Percent Ciprofloxacin Resistant
Heterosexual
Men who have sex with men (MSM)
0
5
10
15
20
25
2001 2002 2003 2004
